Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Jonathan Piccini, MD, MHS, Associate Professor of Medicine at Duke University and Duke Clinical Research Institute discusses goals for his forthcoming CHANGE AFib clinical trial. Dr. Piccini emphasizes…
Part 1 – Case Presentation Gabriel N. Mannis, MD, presents the case of patient “J.A.” to fellow faculty members Brian A. Jonas, MD, PhD, FACP, and Daniel A.…
Part 2 – Case Discussion Gabriel N. Mannis, MD, presents the case of patient “J.A.” to fellow faculty members Brian A. Jonas, MD, PhD, FACP, and Daniel A.…
Part 3 – Case Discussion & Wrap-up Gabriel N. Mannis, MD, presents the case of patient “J.A.” to fellow faculty members Brian A. Jonas, MD, PhD, FACP, and…
Part 1 – Case Presentation Brian A. Jonas, MD, PhD, FACP, presents the case of patient “C.O.” to fellow faculty members Daniel A. Pollyea, MD, MS, and Gabriel…
Part 2 – Case Discussion Brian A. Jonas, MD, PhD, FACP, presents the case of patient “C.O.” to fellow faculty members Daniel A. Pollyea, MD, MS, and Gabriel…
Part 3 – Case Discussion & Wrap-up Brian A. Jonas, MD, PhD, FACP, presents the case of patient “C.O.” to fellow faculty members Daniel A. Pollyea, MD, MS,…
